Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA7 | P43166 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.42 |
| ▸ | RECQL | P46063 | 5/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | DBH | P09172 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27486346 | 0.85 | NR1H4 (0.41) | CA2CA1GAAMAPTLMNA | |
| SCHEMBL1805554 | 0.84 | GAA (0.47) | CA2CA12CA1CA7CA9 | |
| SCHEMBL28477219 | 0.84 | GAA (0.47) | CA2CA12CA1CA7CA9 | |
| SCHEMBL28348813 | 0.84 | GAA (0.47) | CA2CA12CA1CA7CA9 | |
| SCHEMBL9413229 | 0.83 | TUBB1 (0.46) | GAAALOX15TSHRNFKB1BLM | |
| SCHEMBL9413246 | 0.83 | SLC22A6 (0.47) | KDM4EGAATDP1TSHRNFKB1 | |
| SCHEMBL15679089 | 0.83 | ELANE (0.48) | CA2CA12CA1CA7CA9 | |
| SCHEMBL2402636 | 0.83 | ELANE (0.48) | CA2CA12CA1CA7CA9 | |
| SCHEMBL23493150 | 0.82 | ELANE (0.55) | MAPTLMNANFKB1HSD17B10POLB | |
| SCHEMBL15679080 | 0.82 | ELANE (0.55) | MAPTLMNANFKB1HSD17B10POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 293 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116845483-B | Composite diaphragm, preparation method thereof and secondary battery | 天津市捷威动力工业有限公司 | 2023-11-28 | — | — | CN | claimed |
| EP-4253531-A2 | COMPOSITIONS AND METHODS FOR MAKING BENZYLISOQUINOLINE ALKALOIDS, MORPHINAN ALKALOIDS, THEBAINE, AND DERIVATIVES THEREOF | Antheia, Inc. (US) | 2023-10-04 | — | — | EP | claimed |
| CN-116845483-A | Composite diaphragm, preparation method thereof and secondary battery | 天津市捷威动力工业有限公司 | 2023-10-03 | — | — | CN | claimed |
| EP-3475417-B1 | COMPOSITIONS AND METHODS FOR MAKING BENZYLISOQUINOLINE ALKALOIDS, MORPHINAN ALKALOIDS, THEBAINE, AND DERIVATIVES THEREOF | ANTHEIA INC (US) | 2023-05-24 | — | — | EP | claimed |
| US-11377741-B2 | Method for producing a heat exchanger | MAHLE INTERNATIONAL GMBH | 2022-07-05 | — | — | US | claimed |
| EP-3475417-A1 | COMPOSITIONS AND METHODS FOR MAKING BENZYLISOQUINOLINE ALKALOIDS, MORPHINAN ALKALOIDS, THEBAINE, AND DERIVATIVES THEREOF | Intrexon Corporation (US) | 2019-05-01 | — | — | EP | claimed |
| US-20180305820-A1 | METHOD FOR PRODUCING A HEAT EXCHANGER | MAHLE INTERNATIONAL GMBH (DE) | 2018-10-25 | — | — | US | claimed |
| US-20180245127-A1 | RAPID PEPTIDOGLYCAN-BASED ASSAY FOR DETECTION OF BACTERIAL CONTAMINATION | IMMUNETICS, INC. | 2018-08-30 | — | — | US | claimed |
| WO-2018005553-A1 | COMPOSITIONS AND METHODS FOR MAKING BENZYLISOQUINOLINE ALKALOIDS, MORPHINAN ALKALOIDS, THEBAINE, AND DERIVATIVES THEREOF | INTREXON CORPORATION (US) | 2018-01-04 | — | — | WO | claimed |
| US-20170210843-A1 | DURABLE HYDROGEN BONDED HYDROGELS | SUPRAPOLIX B.V. (NL) | 2017-07-27 | — | — | US | claimed |
| WO-2005045065-A1 | RAPID PEPTIDOGLYCAN-BASED ASSAY FOR DETECTION OF BACTERIAL CONTAMINATION OF PLATELETS | IMMUNETICS, INC. (US) | 2005-05-19 | — | — | WO | claimed |
| US-20020037259-A1 | Compositions for controlling bacterial colonization | BUDNY JOHN A (US) | 2002-03-28 | — | — | US | claimed |
| US-6159447-A | Compositions for controlling bacterial colonization | PHARMACAL BIOTECHNOLOGIES, LLC (US) | 2000-12-12 | — | — | US | claimed |
| EP-0750490-B1 | ISATIN DERIVATIVES FOR DYEING KERATIN-CONTAINING FIBRES | HENKEL KGAA (DE) | 2000-11-08 | — | — | EP | claimed |
| EP-0961779-A1 | SUBSTITUTED AMINO BICYCLIC-$g(b)-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS | SYNPHAR LABORATORIES INC. (CA) | 1999-12-08 | — | — | EP | claimed |
| WO-1998032766-A1 | SUBSTITUTED AMINO BICYCLIC-β-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS | SYNPHAR LABORATORIES INC. (US) | 1998-07-30 | — | — | WO | claimed |
| US-5743919-A | HAIR DYES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1998-04-28 | — | — | US | claimed |
| US-5611817-A | HAIR DYES, COLORFASTNESS | HENKEL AG & CO. KGAA (DE) | 1997-03-18 | — | — | US | claimed |
| EP-0695163-B1 | ISATIN DERIVATIVES FOR DYEING KERATIN-CONTAINING FIBRES | HENKEL KGAA (DE) | 1997-03-05 | — | — | EP | claimed |
| US-4380646-A | Method for the N-acylation of aminocarboxylic acids | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) | 1983-04-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170210843-A1 | DURABLE HYDROGEN BONDED HYDROGELS | CD44, RAD51, RAD54L | CA2 4788/4885CA12 3761/4885CA1 4105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.